|Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)|
|(what is: / ?)|
Heme arginate (or haem arginate) is a compound of heme and arginine used in the treatment of acute porphyrias. This heme product is only available outside the United States and is equivalent to hematin.
Heme arginate is a heme compound, whereby L-arginine is added to prevent rapid degradation. It is given intravenously, and its action of mechanism is to reduce the overproduction of δ-aminolevulinic acid, which can cause the acute symptoms in an attack of the acute porphyrias. 
- "HAEM ARGINATE FOR THE ACUTE ATTACK OF PORPHYRIA". Porphyria South Africa.
- "Treatment of the Acute Attack". European Porphyria Network. Retrieved 28 August 2011.
- "Panhematin for Acute Porphyria". American Porphyria Foundation. Retrieved 28 August 2011.
- Volin, L; V Rasi, E Vahtera and R Tenhunen (1988). "Heme arginate: effects on hemostasis". Blood Journal 71: 625–628. Retrieved 28 August 2011.